"Our board-certified dermatologists diagnose and treat the full scope of every single one of our patients individual skin conditions, from the most common to the most rare and complex. We reverse the effects of sun, stress, and life experiences to improve your appearance and confidence. Using the latest technologies and offering the most advanced treatment available, we are here for you."

During the past decade, Dermatology Associates of Seattle conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Associates of Seattle" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Associates of Seattle" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Dermatology Associates, PLLC" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Associates of Seattle" are "Psoriasis" (10 trials), "Atopic Dermatitis" (5 trials), "Dermatitis, Atopic" (2 trials), "Plaque Psoriasis" (2 trials) and "Acne Inversa" (1 trials). Many other conditions were trialed in "Dermatology Associates of Seattle" in a lesser frequency.

Most popular intervention types in "Dermatology Associates of Seattle" are "Drug" (19 trials), "Biological" (3 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etanercept" (3 trials), "Apremilast" (2 trials), "BMS-986165" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Associates of Seattle" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Associates of Seattle". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Dermatology Associates of Seattle, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Associates of Seattle, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".